Registro:

Referencias:

• Bachmann, F., Plasminogen-plasmin enzyme system (2001) Basic Principles and clinical practice, pp. 275-320. , Hemostasis and Thrombosis. Colman R.W., Hirsh J., Marder V.J., Clowes A.W., and George J.N. (Eds), Lippincott Williams & Wilkins, Philadelphia, LA, USA
• Holvoet, P., Lijnen, H.R., Collen, D., A monoclonal antibody specific for Lys-plasminogen (1985) J Biol Chem, 260 (22), pp. 12106-12111
• Casu, B., Structural features and binding properties of chondroitin sulfate, dermatan sulfate and heparan sulfate (1991) Semin Thromb Hemost, 17 (1), pp. 9-14
• Andrew, M.A., Mitchell, L., Berry, L., Paes, B., Delorme, M., Ofosu, F., An anticoagulant dermatan sulfate proteoglycan circulates in pregnant woman and her fetus (1992) J Clin Invest, 89 (1), pp. 321-326
• Delorme, M.A., Saees, N., Sevick, A., Mitchell, L., Berry, L., Johnston, M., Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis (1993) Blood, 82, pp. 3380-3385
• Rossi, E., Duboscq, C., Peragallo, M., Kordich, L., Heparin cofactor II (HC II) and dermatan sulfate plasmatic levels in acute burnt patients (1997) Thromb Haemost, p. 435. , Suppl
• Duboscq, C., Rossi, E., Quintana, I., Kordich, L., Actividad del cofactor II de la heparina y concentración de dermatán sulfato en pacientes sépticos (1994) Medicina, 54 (5-2), p. 509
• Tollefsen, D.M., Pestka, C.A., Monafo, W.J., Activation of heparin cofactor II by dermatan sulfate (1983) J Biol Chem, 258 (11), pp. 6713-6716
• Han, J.H., Cote, H.C.F., Tollefsen, D.M., Inhibition of meizothrombin and meizothrombin(des F1) by heparin cofactor II (1997) J Biol Chem, 272, pp. 28660-28665
• Bock, S.C., Antithrombin III and heparin cofactor II (2006) Basis Principles and Clinical Practice, pp. 235-248. , Hemostasis and Thrombosis. Colman R.W., Clowes A.W., Goldhaber S.Z., Marder V.J., and George J.N. (Eds), Lippincott Williams & Wilkins, Philadelphia-United States
• Barbanti, M., Calani, F., Babbini, M., Bergonzini, G., Parma, B., Marchi, E., Antithrombotic activity of Desmin 370 comparison with a high molecular weight dermatan sulphate (1993) Thromb Res, 71, pp. 417-422
• Agnelli, G., Cosmi, B., Di Filippo, P., Ranucci, V., Veschi, F., Longetti, M., A randomized, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture (1992) Thromb Haemost, 67, pp. 203-208
• Prandoni, P., Meduri, F., Cuppini, S., Toniato, A., Zangrandi, Z., Polisterna, P., Dermatan sulphate: a safe approach to prevention of post operative deep vein thrombosis (1992) Br J Surg, 79, pp. 505-509
• Kretz, J., Chakje, N., Wiesel, M.L., Grunebaum, L., Zamboni, V., Palazzini, E., The treatment of deep vein thrombosis with intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study (1996) Thromb Res, 84 (6), pp. 391-398
• Von Kemp, K., Jochmans, K., Tussenbroek, F., Debruyne, H., Van den Brade, P., Desmin (a low molecular weight dermatan sulfate) versus heparin in treatment of patients with deep venous thrombosis (1998) Eur J Clin Pharmacol, 54 (2), pp. 133-139
• Attanasio, E., Russo, P., Carunchio, G., Caprino, L., Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer. A cost-effectiveness analysis (2001) Pharmacoeconomics, 19 (1), pp. 57-68
• Taliani, M.R., Agnelli, G., Nenci, G.G., Gianese, F., Dermatan sulfate in patients with heparin-induced thrombocytopenia (1999) Br J Haematol, 104, pp. 87-89
• Imberti, D., Verso, M., Silvestrini, E., Taliani, M.R., Agnelli, G., Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism (2003) J Thromb Haemost, 1, pp. 2696-2697
• Boccardo, P., Melacini, D., Rota, S., Mecca, G., Boletta, A., Casiraghi, F., Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure (1997) Nephrol Dial Transplant, 12 (11), pp. 2349-2354
• Ryan, K.E., Lane, D.A., Flynn, A., Ireland, H., Boisclair, M., Shepperd, J., Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure (1992) Thromb Haemost, 68 (5), pp. 563-569
• Van Ryn-McKenna, J., Weber, E.G.E., Ofosu, F.A., Buchnan, M.R., Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli (1989) Thromb Haemost, 61 (1), pp. 7-9
• Van Ryn-McKenna, J., Ofosu, F.A., Gray, E., Hirsh, J., Buchanan, M.R., Effects of dermatan sulphate and heparin on inhibition of thrombus growth in vivo (1989) Ann NY Acad Sci, 556, pp. 304-312
• Carrie, D., Caranobe, C., Gabaig, A.M., Larroche, M., Boneu, B., Effects of heparin, dermatan sulphate and of their association on the inhibition of venous thrombosis growth in the rabbit (1992) Thromb Haemost, 68 (6), pp. 637-641
• Santoro, F.M., Alvarez, R., Fussi, F., Pharmacological profile of a native dermatan sulphate (1992) Thromb Res, 67 (2), pp. 201-211
• Barbanti, M., Calanni, F., Milani, M.R., Marchi, E., Semerano, N., Colucci, M., Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis. Evidence for an anticoagulant-independent mechanism (1993) Thromb Haemost, 69 (2), pp. 147-151
• Colucci, M., Sardella, L., Barbanti, M., Calanni, F., Semerano, N., Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats (1997) Thromb Res, 87 (5), pp. 441-446
• Colucci, M., Rossiello, M.R., Barbanti, M., Calanni, F., Semerano, N., Prevention and therapy of experimental venous trombosis in rabbits by Desmin 370 (1998) Thromb Haemost, 80, pp. 338-341
• Barbanti, M., Calanni, F., Marchi, E., Semerano, N., Colucci, M., Desmin 370, a low molecular weight dermatan sulphate, reduces the weight of performed thrombi in rats made afibrinogenemic by ancrod (1995) Thromb Haemost, 73 (2), pp. 287-290
• Tripodi, A., Moia, M., Bottasso, B., Tenconi, P.M., Gianese, F., Mannucci, P.M., Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers (1991) Thromb Res, 62 (6), pp. 663-672
• Dettori, A.G., Galli, G., Manotti, C., Palazzini, E., Pharmacological activity of a low molecular weight dermatan sulfate (Desmin) in healthy volunteers (1994) Semin Thromb Hemost, 20 (3), pp. 259-265
• Harenberg, J., Jeschek, M., Acker, M., Malsch, R., Huhle, G., Heene, D.L., Effect of low-molecular-weight dermatan sulphate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers (1996) Blood Coagul Fibrinolysis, 7 (1), pp. 49-56
• Abbadini, M., Zhu, G.J., Maggi, A., Pangrazzi, J., Donati, M.B., Mussoni, L., Dermatan sulphate induces plasminogen activator release in perfused rat hindquarters (1987) Blood, 70 (6), pp. 1858-1860
• Krupinski, K., Bielawiec, M., Yoshida, K., Kyogashima, M., Takada, Y., Takada, A., Dermatan sulphate enhances lysis of laser induced thrombus in vivo (1998) Thromb Res, 91, pp. 199-202
• Marsh, N.A., Minter, A.J., Chesterman, C.N., The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells (1990) Blood Coagul Fibrinolysis, 1 (2), pp. 133-138
• Kyogashima, M., Onaya, J., Miyauchi, S., Arai, M., Shibata, Y., Suda, A., Antithrombotic activity of avian crown dermatan sulphate (1999) Thromb Res, 96, pp. 459-465
• Paques, E.P., Stohr, H.A., Heimburger, N., Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin (1986) Thromb Res, 42, pp. 797-807
• Takada, Y., Urano, T., Takada, A., Effects of heparan sulfated analogue or other sulphate polysaccharides on the activation of plasminogen by t-PA and u-PA (1994) Thromb Res, 73 (5), pp. 301-311
• Andrade-Gordon, P., Strickland, S., Interaction of heparin with plasminogen activators and plasminogen: Effects on the activation of plasminogen (1986) Biochemistry, 25, pp. 4033-4040
• Stein, P.L., Van Zonneveld, A.J., Pannekoek, H., Strickland, S., Structural domains of human-type plasminogen activator that confer stimulation by heparin (1989) J Biol Chem, 264 (26), pp. 15441-15444
• Stephens, R.W., Bokman, A.M., Myohanen, H.T., Reisberg, T., Tapiovaara, H., Pedersen, N., Heparin binding to the urokinase kringle domain (1992) Biochemistry, 31, pp. 7572-7579
• Liang, J.F., Li, Y., Yang, V., The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation (2000) Thromb Res, 97, pp. 349-358
• Takada, A., Takada, Y., Sugawara, Y., Effects of fibrinogen and fibrin on the activation of Glu- and Lys-Plasminogen by urokinase (1984) Thromb Res, 33, pp. 561-569
• Laemmli, K.V., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685
• Rydzewski, A., Takada, Y., Takada, A., Stimulation of plasmin catalyzed conversion of single-chain to two chain urokinase-type plasminogen activator by sulphated polysaccharides (1989) Thromb Haemost, 62 (2), pp. 752-755
• Dosne, A.M., Bendetowitz, A.V., Kher, A., Samama, M., Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and low molecular weight heparin (1988) Thromb Res, 51, pp. 627-630
• Mangel, W.F., Lin, B.H., Ramakrishanan, V., Characterization of an extremely large, ligand-induced conformational change in plasminogen (1990) Science, 248 (4951), pp. 69-73
• Markus, G., Evers, J.L., Hobika, G.H., Comparison of some properties of native (Glu) and modified (Lys) human plasminogen (1978) J Biol Chem, 253 (3), pp. 733-739
• Andrade-Gordon, P., Strickland, S., Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by t-PA (1989) J Biol Chem, 264 (26), pp. 15177-15181
• Edelberg, J.M., Weissler, M., Pizzo, S.V., Heparin oligosaccharides enhance t-PA: a correlation between oligosaccharide length and stimulation of plasminogen activation (1991) Biochemistry, 30, pp. 10999-11003

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------